PATENT CLAIM ANALYSIS

Application Number: 16028221
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-11
Patent Classification: ["514", "055000"]

Abstract:
The present invention relates generally to therapeutic compositions comprising chitosan-derived compositions used in connection with methods for treating neoplasms, such as for instance, malignant lung, thyroid and kidney neoplasms, and other types of malignant neoplasms, and other medical disorders.

Claim (Index 8):
An injectable pharmaceutical composition comprising:\n a) a sterile filtered aqueous mixture of the viscoelastic glycated chitosan polymer of Formula 1, wherein: n is an integer of from about 5 to about 2300 for a molecular weight range of 1000 to less than 500,000 Daltons; and the degree of glycation of free amino groups of the chitosan polymer ranges between about one tenth of one percent to about thirty percent, in which the sterile filtered aqueous mixture has a pH from between 5 to about 7; and b) the sterile filtered aqueous mixture having about one percent by weight of the viscoelastic glycated chitosan polymer dissolved therein so that the sterile filtered aqueous mixture has a viscosity from about one centistokes to approximately one hundred centistokes measured at about 25 degrees Celsius.

Metadata:
- Claim Count in Document: 21.0
- Percentile: 95.0
- Lexical Diversity: 1.36364
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13037171', '13755105', '10870342', '12404879', '13502818']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6711753071619657
- 35 USC 102 Novelty (BERT): 0.5071094043245522
- Combined Prediction Score: 0.6547687168782244
- Mean Citation Score: 151.17314
- Max Citation Score: 174.05624
- Similarity Product: 102.32800288521769

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test